Skip to Content

Novartis AG Registered Shares

NOVN: XSWX (CHE)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
CHF 62.00GddDrzdshsj

Novartis Earnings: Better-Than-Expected Broad-Based Results Support Fair Value Estimate Increase

Novartis reported first-quarter results ahead of our expectations, and we've increased our fair value estimate to $105 (CHF 96 local share class) from $98 (CHF 88). Strong top-line growth combined with core margin expansion sets up the company well to meet management’s raised 2024 guidance of low-double-digit to midteens earnings growth.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of NOVN so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center